Optinose
optinose.com
Actively hiring
Specialist Medical Practices
Prescription Drugs
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$49.4M
5 rounds on record
Latest round
$4.7M
Venture round · May 2024 · 2 yr ago
Team
501-1000
employees, estimated range
Backers
1
Foresite Capital
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 20, 2024
Board appointment Kyle Dempsey, Director · SEC Form D
May 10, 2024
Raised a round Venture round $4.7M · SEC Form D
Nov 30, 2021
Board appointment Tomas Heyman, Director · SEC Form D
Nov 16, 2021
Raised a round Venture round $4M · SEC Form D
Aug 19, 2020
Board appointment Catherine Owen, Director · SEC Form D
Aug 18, 2020
Raised a round Venture round $250k · SEC Form D
Sep 25, 2019
Board appointment Joseph Scodari, Director · SEC Form D
Sep 12, 2019
Raised a round Venture round $5.4M · SEC Form D
Mar 24, 2017
Raised a round Venture round $35M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2024 | $4.7M | — | SEC Form D |
| Venture round | Nov 2021 | $4M | — | SEC Form D |
| Venture round | Aug 2020 | $250k | — | SEC Form D |
| Venture round | Sep 2019 | $5.4M | — | SEC Form D |
| Venture round | Mar 2017 | $35M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | OptiNose, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Ramy MahmoudDirector, Executive OfficerSEC Form D
Keith GoldanExecutive OfficerSEC Form D
Peter MillerExecutive Officer, DirectorSEC Form D
Michael MarinoExecutive OfficerSEC Form D
Tom GibbsExecutive OfficerSEC Form D
Victor ClavelliExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Foresite Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Azurity Pharmaceuticals is a privately held specialty pharmaceutical company that develops and markets medicines for patients underserved…
PleoPharma pharmaceutical company homepage, management team, product offering, contact us.
Together for Health. Noucor Completes Acquisition of HELM Pharmaceutical.
Validproof assists pharmaceutical companies meet their traceability obligation and ensure that their medicine makes it into the right hands.
At AllergenIQ, our allergist offers at-home allergy testing and tailored treatment plans for kids and parents. Book your virtual…
Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and…
Overview
Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists.
People
Ramy Mahmoud
Director, Executive Officer
Keith Goldan
Executive Officer
Peter Miller
Executive Officer, Director
Michael Marino
Executive Officer
Tom Gibbs
Executive Officer
Victor Clavelli
Executive Officer
Paul Spence
Executive Officer
Anthony Krick
Executive Officer
Joshua Tamaroff
Director
Patrick O'Neill
Director
William Doyle
Director
Klaas De Boer
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Yardley
United States
HQ
Worldwide HeadquartersOptiNose US, Inc.
500-1000 est. staff
777 Township Line Road, Suite 300, Yardley, Pennsylvania 19067 USA
Financials
Total raised
$49.4M
Latest round
Venture - Series Unknown
Funding rounds
5